pennbattle35000reel| Freida (600223.SH): Successfully constructed a hyaluronan producing strain and a high-efficiency hyaluronidase expressing strain using synthetic biology technology

Gelonghui May 13 丨 Freida (600223pennbattle35000reel.SH) stated on the interactive platform that the company's Shandong Focus Freida Biotech (600201) Co., Ltd. is one of the world's leading hyaluronic acid raw material production bases, integrating the research and development, production and sales of hyaluronic acid. The company's Shandong Freida Biotech Co., Ltd. mainly carries out the research and development, production and sales of food additives and cosmetic raw materials. Sodium hyaluronate and its derivatives under Shandong Focus Freida Biotech Co., Ltd., the full range of products of Shandong Freida Biotech Co., Ltd., and collagen and hyaluronic acid-related products of Shandong Freida Biotech Co., Ltd. all use biological fermentation technology. In 2020, the company jointly established a joint laboratory with Jiangnan University. After recent years of development, it has successfully used synthetic biology technology to successfully build hyaluronic acid production strains and high-efficiency hyaluronidase expression strains, and successfully applied hyaluronidase to different molecular weights. Precise control of hyaluronic acid and preparation of enzyme-digested low molecules, joint developmentpennbattle35000reelAcetylated hyaluronic acid and other derivatives were introduced.